Article
Detectable BRAF mutation in serum DNA samples from patients with papillary thyroid carcinomas.
Head & neck - 1 Feb 2010
Chuang Tony C Y, Chuang Alice Y C, Poeta Luana, Koch Wayne M, Califano Joseph A, Tufano Ralph P
Abstract excerpt
BACKGROUND.: An activating point mutation of the BRAF oncogene results in a V600E amino acid missense mutation found in a majority of papillary thyroid carcinomas (PTC). METHODS.: In this study, 28 matched tumor and serum samples obtained from patients with both benign and malignant thyroid disor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
